Alteco Medical offers a medical device for extracorporeal blood purification. The product removes endotoxin (lipopolysaccharide, LPS) from the patient’s bloodstream, and is applied as an add-on therapy in sepsis to treat endotoxemia (high levels of endotoxin). This can help stabilize the patient in acute situations. Endotoxemia is often present in sepsis, a life-threatening condition and one of the most common causes of death in modern intensive care.

Quotes for Alteco Medical AB

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Market Value (MSEK)
9,7
Time (Latest trade)

Board

CEO

  • Anders Althin (tf)

Chairperson of the Board

  • Mats Wahlström

Board

  • Anders Althin
  • Charlotte Althin Hicks
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Largest Owners

    Name Capital % Votes % Date
    Anders Althin 89,20 89,20 2024-09-24
    Göran Erlandsson 1,94 1,94 2024-06-26
    Avanza Pension 1,08 1,08 2024-06-26
    Jarl Ingvar Andersson 0,31 0,31 2024-06-26
    Nordnet Pensionsförsäkring 0,31 0,31 2024-06-26
    Magnus Lundberg 0,28 0,28 2024-06-26
    Gunnar Råbe 0,24 0,24 2024-06-26
    Fredrik Nerme 0,23 0,23 2024-06-26
    Anders Berthag 0,23 0,23 2024-06-26
    Handelsbanken Liv Försäkring AB 0,23 0,23 2024-06-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2024-11-21 Delårsrapport 2024-Q3

    Annual reports, prospectus etc.